Amphastar Q1 EPS Drops to $0.42, Misses Consensus by $0.28

AMPH•2026-05-07

Amphastar’s first-quarter EPS came in at $0.42, missing the consensus estimate by $0.28 and down from $0.74 a year earlier. The significant shortfall to the $0.70 consensus highlights a sharp earnings decline that could pressure the stock as investors reevaluate growth prospects.

1. Q1 Earnings Miss Expectations

Amphastar reported first-quarter EPS of $0.42, missing the $0.70 consensus estimate and down from $0.74 in the year-ago period.

Sources

Amphastar: Q1 Earnings Snapshot

Finance

Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates

Zacks

Amphastar Q1 EPS Drops to $0.42, Misses Consensus by $0.28

1. Q1 Earnings Miss Expectations

Related News

Sensata Technologies schedules Q2 2026 results release, earnings call

Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports

BCB Bancorp CEO Thomas M. O’Brien files initial beneficial ownership statement for 709,220 shares

Sources

Amphastar: Q1 Earnings Snapshot

Amphastar Pharmaceuticals (AMPH) Q1 Earnings Lag Estimates

Karooooo Reports Q1 2027 Results With Record Net Subscriber Additions And Accelerating Growth

Home BancShares Q2 FY26 revenue rises 10.6% to $295.1 million; net income climbs to $119.3 million